MedTrace Logo

Strategies to Improve the HIV Care Continuum Among Key Populations in India

NCT02969915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2314

Last updated 2025-12-15

Study results available
· View outcomes & findings →

Summary

This clinical trial will compare the effectiveness of integrated care centers vs. integrated care centers plus HIV patient treatment incentives for achieving HIV treatment targets among people who inject drugs and men who have sex with men in India. The investigators will also assess cost-effectiveness and barriers and facilitators to implementation through targeted mixed-methods approaches. This study is a model for improving HIV treatment outcomes in key populations in low to middle-income countries.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Incentives

Treatment incentives are offered to HIV-positive participants for reaching treatment targets, including retention to medical follow-up, initiating antiretroviral therapy, and maintaining high adherence with antiretroviral therapy.

BEHAVIORAL

Integrated Care Centers

ICCs offer key-population-oriented, vertically-integrated harm reduction, HIV testing, and HIV treatment services

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • YR Gaitonde Centre for AIDS Research and Education

    collaborator OTHER

  • Elton John AIDS Foundation

    collaborator OTHER

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Shruti H Mehta, PhD · Johns Hopkins University

  • Gregory M Lucas, MD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2020-03-23
Completion
2024-05-30

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969915 on ClinicalTrials.gov